Abstract
Soft tissue tumor prognosis is characterized by a wide variability, ranging from neoplasms completely indolent to those very aggressive. The biological behavior is classified by the WHO into three categories: benign, intermediate (including forms that can locally recur and those at low risk of metastasis), and malignant (which are characterized by high risk of metastasis). Of note, some subtypes of soft tissue tumors classified among benign neoplasms can actually behave as tumors of intermediate malignant potential (e.g., cellular and atypical variants of benign fibrous histiocytoma). The present chapter is dedicated to describe the current modalities to determine soft tissue tumors’ prognosis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Suggested Readings
AJCC Cancer Staging Manual (8th edn). Springer; 2017
Andreou (2013) Sentinel node biopsy in soft tissue sarcoma subtypes with a high propensity for regional lymphatic spread—results of a large prospective trial. Ann Oncol 24(5):1400–1405
Callegaro (2016) Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localized soft tissue sarcomas of the extremities: a retrospective analysis. Lancet Oncol 17:671–678
Coindre (2006) Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med 130(10):1448–1453
Ecker (2017) Implications of lymph node evaluation in the management of resectable soft tissue sarcoma. Ann Surg Oncol 24(2):425–433
Gold (2009) Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol 10(11):1045–1052
Pasquali (2018) High-risk soft tissue sarcomas treated with perioperative chemotherapy: improving prognostic classification in a randomised clinical trial. Eur J Cancer 93:28–36
Siegel (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7–30
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mocellin, S. (2021). Prognosis. In: Soft Tissue Tumors . Springer, Cham. https://doi.org/10.1007/978-3-030-58710-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-58710-9_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-58709-3
Online ISBN: 978-3-030-58710-9
eBook Packages: MedicineMedicine (R0)